European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires00:20

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels

Zacks 11/20 23:30

Silence Therapeutics Analyst Ratings

Benzinga11/20 17:46

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst

Benzinga11/20 04:34

Top 3 Health Care Stocks You'll Regret Missing In Q4

Benzinga11/19 20:52

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data At 2024 AHA Annual Meeting; New Zerlasiran Data Show Significant Time-Averaged Lp(a) Reductions With Effects Persisting 60 Weeks Following The First Dose

Benzinga11/19 03:57